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Abstract Bone, air passages, cavities, and lung are elements present in patients, but chall-
enging to properly correct for in treatment planning dose calculations. Plastic scintillator 
detectors (PSDs) have proven to be well suited for dosimetry in non-reference conditions such 
as small fields. The objective of this study was to investigate the performance of a commercial 
treatment planning system (TPS) using a PSD and a specially designed thorax phantom with 
lung tumor inserts. 10 treatment plans of different complexity and phantom configurations 
were evaluated. Although the TPS agreed well with the measurements for the least complex 
tests, deviations of tumor dose > 4% were observed for some cases. This study underpins the 
dosimetric challenge in TPS calculations for clinically relevant heterogeneous geometries. The 
scintillator system, together with the special phantom, provides a promising tool for evaluation 
of complex radiotherapy dose calculations and delivery.  
1.  Introduction 
Fiber-coupled organic plastic scintillator detectors (PSDs) feature advantages suitable for complex and 
dynamic radiation dosimetry in megavoltage photon beams [1-3]. When it comes to heterogeneous 
setups with lack of charged particle equilibrium (CPE), there are recognized calculation challenges for 
most commercial treatment planning systems (TPSs). Thus, volumes containing bone, air passages, 
cavities and lung may deteriorate the TPS dose calculation accuracy [4, 5].  
The objective of this study was to investigate the performance of a TPS dose calculation algorithm 
by using a PSD in a heterogeneous setup, analogous to the geometry of a lung cancer patient, while 
delivering clinical relevant treatment plans of varying complexity. 
2.  Material and methods 
2.1.  Phantom design 
A thorax phantom, analogous to a lung cancer patient, was constructed to perform PSD dosimetry in a 
well-defined heterogeneous geometry. The body of the phantom is made of PMMA, 34 cm in width 
(W), 23 cm in height (H) and 40 cm in length (L) (figure 1). It contains three hollow cylinders of  
L:50 cm, and a diameter (Ø) of 10 cm. These cylinders can be filled with several inserts of various 
materials to simulate different homo- and heterogeneous geometries. The various inserts are made of 
the copolymer polyoxymethylene (POM-C), balsa wood, and PMMA representing bone, lung and soft 
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tissue, respectively (figure 1, table 1-2). The lung inserts were 15 cm long with a Ø of 9 cm, 
mimicking a human lung in size. PMMA spheres of various sizes (1-8 cm in diameter) embedded in 
balsa wood are available to simulate tumors in lung (figure 1 (d)). In the lower part of the body, two 
smaller cylindrical holes of Ø:2 cm and Ø:3 cm (which also can be altered to Ø:2 cm) are positioned at 
different distances from the phantom center, i.e. 6.5 cm and 9.5 cm (table 2). These holes can, one at a 
time, be filled with a POM-C rod to simulate the spinal column at different diameters and position 
from the center of the phantom (table 2). 
 
   
Figure 1. (a) A heterogeneous setup where the two lateral body cylinders are filled with balsa wood 
inserts. (b) A homogeneous setup, where the whole phantom are filled with PMMA inserts. (c) The 
heterogeneous setup described in (a) viewed from the side, where the lateral body cylinder 
containing the lung insert is longitudinal shifted from the central position in the phantom. (d) Balsa 
wood lung insert with associated tumors, ranging from  
1-8 cm in diameter. (Color version of ﬁgure is available online.) 
2.2.  Image acquisition and target definition 
Four phantom configurations (‘Homo.’, ‘Hetero.’, ‘3 cm tumor’ and ‘5 cm tumor’) scanned in a 16 
slice Philips Brilliance CT Big Bore, version 3.5.17001 (Philips Medical Systems, Cleveland, OH) 
using a standard thorax scanning protocol were used in this study (illustrated in table 2). Table 1 
presents the CT image characteristics of the phantom materials of 10 CT series of the phantom 
compared to corresponding human tissue data for 10 randomly picked lung cancer patients.  
 
Table 1. CT image characteristics of the phantom materials compared to human tissue. Mean HU values 
and (range) for 10 CT series of the phantom and corresponding tissue data for 10 randomly picked lung 
cancer patients. Paired t-tests were performed for each tissue type, to check for differences in the mean HU 
value between the phantom material and the patient tissue data. No significances were found, using p < 
0.05, i.e. there are good agreement between human tissue and the phantom materials. 
 
Tissue 
Phantom Material HU
b
  
  Density / [g/cm
3
] Phantom
 
Patients  
 Bone  POM-C 1.40 319 (309;327) 313 (210;413)  
 Lung  Balsa wood 0.10 -913 (-917;-888) -901 (-977;-770)  
 Soft tissue PMMA
a 
1.18 116 (103;123) 118 (84;143)  
 a.
Poly(methyl methacrylate)  
b.
Using a standard thorax CT scanning protocol by Philips. 
 
 
Delineations of the anatomical structures GTV, CTV, PTV, medulla, lung and body were per-
formed on all image sets in the treatment planning system (TPS) Eclipse v. 10 (Varian Medical 
Systems, Palo Alto, CA, USA). CTVs and PTVs were defined as a 5 mm and 10 mm symmetrical 
expansion of GTV, respectively. 
 
 
a c d 
b 
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2.3.  Experimental setup and calibration conditions 
The scintillator used was the BCF-60 (Saint-Gobain Ceramics & Plastics Inc.) with Ø:1 mm and L:2 
mm, described by Beierholm et al [1]. The PSD was calibrated according to the procedure (method C) 
described by Guillot et al [6] in a solid water calibration phantom. Measurements were carried out 
using the ME40 scintillator dosimetry system (DTU Nutech) [2]. The reference dose (100 MU, 10x10 
cm
2
 field) was measured by a Farmer ionization chamber, type 30011 (PTW, Freiburg, Germany) at a 
depth of 10 cm in the PMMA phantom QUASAR Multi-Purpose Body Phantom (Modus Medical 
Devices Inc., London, ON, Canada). Irradiation was delivered by a Varian Clinac iX 2300 linear 
accelerator (Varian Medical Systems), with a beam energy of 6 MV at a dose rate of 600 MU/min [7]. 
The accumulated PSD dose for the various treatment plans were compared with corresponding TPS 
calculated point doses (table 2). 
 
Table 2. TPS calculated isocentric point doses compared with corresponding PSD measured dose. (Color 
version of ﬁgure is available online.) 
Isocenter is positioned in the center of 
the phantom 
 Fiber dose 
 [Gy] 
TPS dose  
[Gy] 
Dose deviation [%] 
Homo. setup Hetero. setup  Homo. Hetero. Homo. Hetero. Homo. Hetero. 
  Conv. 
2.001 2.005 2.000 2.000 -0.1 -0.3 
  
2.005 2.006 2.000 2.000 -0.3 -0.3 
  
RA 1.976 1.953 1.984 1.965 0.4 0.6 
Isocenter is shifted laterally 11 cm 
 
3 cm 
tumor 
5 cm 
tumor 
3 cm 
tumor 
5 cm 
tumor 
3 cm 
tumor 
5 cm 
tumor 3 cm tumor 5 cm tumor 
  
Conv. 2.114 2.083 2.000 2.000 -5.4
 
-4.0 
  
RA 2.323 2.203 2.268 2.175 -2.4
a
 -1.3 
a.
 The dose deviation per arc was as large as -7.6%. 
2.4.  Treatment plans and delivery 
In total, 10 treatment plans of different phantom configurations and isocentric field techniques (single 
field, 4-field conventional and two-arc RapidArc (RA) plans) were created. For each treatment plan 
the isocenter was positioned in the center of the GTV. For six treatment plans the isocenter was 
positioned centrally in the phantom. Three of these had a homogenous setup (figure 1 (b), table 2), and 
three of them had a heterogeneous setup (figure 1 (a), table 2). For the remaining four treatment plans 
the isocenter were shifted 11 cm laterally, because the GTVs were situated in the left lung of the 
phantom (table 2). Doses were calculated using the AAA algorithm, with a prescribed dose of 2 Gy to 
the PTV. The RA plans were normalized to the mean dose of the PTV, while the other plans were 
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normalized to the isocenter. All treatment plans satisfied the clinical dose coverage criteria. For the 
tumors situated in the lung 98% of the PTV volume was covered by minimum 90% of the prescribed 
dose. For the treatment plans not situated in the lung the corresponding dose coverage was 95%. The 
beam energy and dose rate used were 6 MV and 600 MU/min, respectively. 
3.  Results/Discussion 
Under calibration conditions the PSDs agreed with the TPS calculations to 0.1%. 
Deviations less than 1% were observed between calculated and measured doses when the isocenter 
was located in the middle of the phantom. For the homogeneous configuration, deviations were in the 
range of (-0.1%;0.4%) and for the heterogeneous configuration, deviations were in the range 
of (-0.3%; 0.6%) (table 2). The RA plans generally resulted in larger total dose deviation (0.4%;0.6%) 
compared with the simple conventional techniques (-0.3%;-0.1%). These low discrepancies, for the 
centrally positioned point in the phantom, probably illustrate that there is enough distance to adjacent 
heterogeneities in the phantom to be able to establish CPE. Larger TPS dose deviations (-5.4%;-1.3%) 
were observed when the isocenter was shifted laterally, since the GTV was situated in the left lung of 
the phantom. These substantial deviations could potentially be due to lack of sufficient spread of 
lateral radiation to obtain CPE. Even larger dose deviations (-5.4%;-2.4%) were observed for the 
smallest tumor size investigated (3 cm in diameter). This small size of tumor is not large enough to re-
establish the CPE condition, and this is most likely the reason why the smallest tumor size results in 
the highest dose deviation. For the laterally shifted phantom configuration, the simple conventional 
technique resulted in a higher total dose deviation (-5.4%;-4.0%) compared to the more complex RA     
(-2.4%;-1.3%). The lower dose deviation, when using RA, might be due to the spread of incident 
radiation over the whole phantom compared to limited incident angles through heterogeneous 
medium, when using conventional technique.  
4.  Conclusion 
Dose deviations of < 1% were observed for isocentric field techniques centered in the middle of the 
phantom, whereas dose deviations > 4% were observed for some laterally shifted treatment plans. The 
study confirmed that the smallest tumor size results in the highest dose deviation. The scintillator 
system and the heterogeneous phantom provide a promising tool for critical evaluations of complex 
radiotherapy calculations and dose delivery.  
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